PDE10A
protein-codingphosphodiesterase 10A, the group of Phosphodiesterases
Gene summary
The protein encoded by this gene belongs to the cyclic nucleotide phosphodiesterase family. It plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This protein can hydrolyze both cAMP and cGMP to the corresponding nucleoside 5' monophosphate, but has higher affinity for cAMP, and is more efficient with cAMP as substrate. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Dec 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~660.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014835
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0044332
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014835
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0044637
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014835
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014835
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014835
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0014834
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0044637
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014834
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: Neurologic
Rationale: In Striatal degeneration, autosomal dominant 2, treatment with levodopa has been described as beneficial in some individuals who developed Parkinsonism
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PDE10A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001385079.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 63 | 7 | 75 | ||
| missense | 3 | 5 | 128 | 6 | 142 | |
| nonsense | 1 | 1 | 5 | 7 | ||
| start loss | 0 | |||||
| frameshift | 4 | 5 | 9 | |||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 4 | 10 | 147 | 69 | 7 | 237 |
Highest pathogenic variant AF is 0.0000027533988
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001372008.1 | 22 | MANE Select | |
| Ensembl | ENSP00000438284.3 | 22 | MANE Select | |
| RefSeq | NP_001124162.1 | 22 | Standard | |
| RefSeq | NP_006652.1 | 22 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Purine metabolism - Homo sapiens (human)
- Morphine addiction - Homo sapiens (human)
- Purine Nucleoside Phosphorylase Deficiency
- Mercaptopurine Action Pathway
- Azathioprine Action Pathway
Biological Process
- cAMP catabolic process
- G protein-coupled receptor signaling pathway
- regulation of protein kinase A signaling
- negative regulation of cGMP-mediated signaling
- negative regulation of cAMP-mediated signaling
Molecular Function
- 3',5'-cyclic-nucleotide phosphodiesterase activity
- 3',5'-cyclic-AMP phosphodiesterase activity
- cGMP-stimulated cyclic-nucleotide phosphodiesterase activity
- cAMP binding
- cGMP binding
Cellular Component
- cytosol
- membrane
- perikaryon
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000539869
- Coding exons
- 22
- Length
- 659316
- Individuals with no LoFs
- 125739
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 9
- Defined
- 125748
- p
- 0.0000358
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.76 | 222 | 445 | 0.499 | 0.0000241 | 5200 |
| Missense (PolyPhen) | 54 | 166.1 | 0.32511 | 1936 | ||
| Synonymous | 0.258 | 156 | 160 | 0.974 | 0.00000901 | 1462 |
| Loss of Function | 5.51 | 4 | 43.0 | 0.0931 | 0.00000200 | 547 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00034 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. Can hydrolyze both cAMP and cGMP, but has higher affinity for cAMP and is more efficient with cAMP as substrate. May play a critical role in regulating cAMP and cGMP levels in the striatum, a region of the brain that contributes to the control of movement and cognition. {ECO:0000250|UniProtKB:Q8CA95, ECO:0000269|PubMed:17389385}.;
- Disease
- DISEASE: Dyskinesia, limb and orofacial, infantile-onset (IOLOD) [MIM:616921]: An autosomal recessive, early-onset hyperkinetic movement disorder characterized by axial hypotonia, dyskinesia of the limbs and trunk, orofacial dyskinesia, drooling, and dysarthria. The severity of the hyperkinesis is variable. {ECO:0000269|PubMed:27058446}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Striatal degeneration, autosomal dominant 2 (ADSD2) [MIM:616922]: An autosomal dominant disorder characterized by striatal degeneration and dysfunction of basal ganglia, resulting in hyperkinesis. {ECO:0000269|PubMed:27058447}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- LoFtool
- 0.378
- RVIS EVS
- -0.98
- RVIS percentile EVS
- 8.8
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.733
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |